原料药
Bepotastine besilate
KDMF APIs
Bepotastine besilate
韩文名称 | 베포타스틴베실산염 |
|---|---|
分类 | 抗过敏药 |
CAS No. | 125602-71-3 |
KDMF 登记号 | 20190926-209-J-357 |
生产厂商 | Bal Pharma Limited |
规格 | JP |
品目信息
IUPAC Name | 4-{4-[(4-chlorophenyl)(pyridin-2-yl)methoxy]piperidin-1-yl}butanoic acid |
|---|---|
Description | Bepotastine is a non-sedating, selective antagonist of the histamine 1 (H1) receptor. Bepotastine was approved in Japan for use in the treatment of allergic rhinitis and uriticaria/puritus in July 2000 and January 2002, respectively, and is marketed by Tanabe Seiyaku Co., Ltd. under the brand name Talion. It is available in oral and opthalmic dosage forms in Japan. The opthalmic solution is FDA approved since Sept 8, 2009 and is under the brand name Bepreve. |
Certificate of Analysis | If you need more information, please contact us. |
如需规格书 · 检验成绩书等附加资料，请在咨询时一并提出。负责人确认后将回复您。（02-579-1056 · ace@acebiopharm.com）